Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_provenance.
- NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_assertion description "[Screening of the expression of the CDR3 in other gastric cancer patients is recommended to develop an immuno-therapy of gastric cancer based on antigenic peptide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_provenance.
- NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_assertion evidence source_evidence_literature NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_provenance.
- NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_assertion SIO_000772 10470148 NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_provenance.
- NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_assertion wasDerivedFrom befree-2016 NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_provenance.
- NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_assertion wasGeneratedBy ECO_0000203 NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_provenance.
- befree-2016 importedOn "2016-02-19" NP261898.RABGrqZw2dnFQ3en5KU8jNzztU5uEseihWKc6PWHDn-Lk130_provenance.